Search
for

    Sort by

    Research 781–810 of 1000+

    1. Additive in vivo growth-inhibitory effects of flutamide and finasteride on androgen-sensitive Shionogi 115 carcinoma Endocrine-related Cancer · 1996 · 6 citations
    2. Cutaneous manifestations of polycystic ovary syndrome Current Opinion in Endocrine and Metabolic Research · 2020 · 5 citations
    3. Effects of Exercise Combined with Finasteride on Hormone and Ovarian Function in Polycystic Ovary Syndrome Rats International Journal of Endocrinology · 2019 · 5 citations
    4. Acne in Dark Skin Springer eBooks · 2018 · 5 citations
    5. Endocrine disorders and hormonal therapy for adolescent acne Current Opinion in Pediatrics · 2017 · 5 citations
    6. The anti-androgen combination, flutamide plus finasteride, paradoxically suppressed LH and androgen concentrations in pregnant spotted hyenas, but not in males General and Comparative Endocrinology · 2010 · 5 citations
    7. Healthy Lifestyle and Dietary Approaches to Treating Polycystic Ovary Syndrome: A Review Open Health · 2022 · 4 citations
    8. Comparison of Finasteride, Metformin, and Finasteride Plus Metformin in PCOS Acta Endocrinologica · 2017 · 4 citations
    9. Steroid inhibitors of androgen-potentiated actions on skin 1983 · 4 citations
    10. The inflammatory component of androgenetic alopecia Journal of The American Academy of Dermatology · 2021 · 3 citations
    11. Bladder cancer survival in men using 5-alpha-reductase inhibitors European Urology Supplements · 2018 · 3 citations
    12. Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists Bioorganic & medicinal chemistry letters · 2017 · 3 citations
    13. Hair aging and anti-aging Expert Review of Dermatology · 2007 · 3 citations
    14. Connarus semidecandrus Jack Exerts Anti-Alopecia Effects by Targeting 5α-Reductase Activity and an Intrinsic Apoptotic Pathway Molecules · 2022 · 2 citations
    15. TMPRSS2, required for SARS-CoV-2 entry, is downregulated in lung cells by enzalutamide, a prostate cancer therapeutic Research Square (Research Square) · 2020 · 2 citations
    16. The impact of obesity on the folliculosebaceous unit Journal of The American Academy of Dermatology · 2014 · 2 citations
    17. Understanding polycystic ovary syndrome Nurse Prescribing · 2009 · 2 citations
    18. Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies Scientific Reports · 2025 · 1 citations
    19. Bicalutamide in Dermatology: A Narrative Review Indian Dermatology Online Journal · 2024 · 1 citations
    20. Virilización y enfermedad metabólica en mujer postmenopáusica relacionado a hiperplasia e hipertecosis ovárica Revista de la Facultad de Ciencias Médicas de Córdoba · 2021 · 1 citations
    21. Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2 Research Square (Research Square) · 2021 · 1 citations
    22. The effect of GGC and CAG repeat polymorphisms on the androgen receptor gene in response to finasteride therapy in men with androgenetic alopecia Journal of Research in Medical Sciences · 2019 · 1 citations
    23. Pathogenesis and causes of hirsutism 2006 · 1 citations
    24. Hormonal Therapy for Acne Journal of Cutaneous Medicine and Surgery · 1996 · 1 citations
    25. A case of severe hyperandrogenism, acanthosis nigricans and overt diabetes: the use of non-invasive methods for diagnosis, pathogenesis and management Gynecological endocrinology · 1996 · 1 citations
    26. [Androgenetic alopecia in the male. Recent developments]. PubMed · 1989 · 1 citations
    27. A Review of Therapeutic Applications of Nutraceuticals in Polycystic Ovarian Disease Journal of Pharma Insights and Research. · 2025 · 1 citations
    28. The Pilocutaneous Syndrome of Menopause Figshare · 2026
    29. Poor Therapeutic Response in Female Pattern Hair Loss: Mechanisms and a Practical Framework for Clinical Management Skin Appendage Disorders · 2026
    30. 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy Open MIND · 2026